Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li-na Tang

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Huan Jing Ke Xue= Huanjing Kexue|December 17, 2008
[Photocatalytic reduction of nitrate using metal-doped titania]Li-na Tang, Li-fen Liu, Xiao-yan Dong, et al.
Ying Yong Sheng Tai Xue Bao = the Journal of Applied Ecology|April 19, 2008
[Ecological classification system of forest landscape in eastern mountainous region of Liaoning Province]Li-na Tang, Qing-li Wang, Li-min Dai, et al.
World Journal of Gastrointestinal Oncology|April 16, 2025
Clinical observation of nivolumab combined with cabozantinib in the treatment of advanced hepatocellular carcinomaLu-Wen Liang, Rong-Hong Luo, Zhi-Li Huang, et al.
Oncology Letters|October 8, 2014
Comparison of pemetrexed plus cisplatin with gemcitabine plus docetaxel in refractory/metastatic osteosarcoma: Clinical outcomes from a retrospective database monitored in a single instituteWen-Xi Yu, Li-Na Tang, Feng Lin, et al.
Journal of Cancer Research and Clinical Oncology|January 20, 2012
Effectiveness and safety of pemetrexed-based doublet versus pemetrexed alone as second-line treatment for advanced non-small-cell lung cancer: a systematic review and meta-analysisWei-Xiang Qi, Li-Na Tang, Ai-Na He, et al.
Critical Reviews in Oncology/Hematology|November 5, 2013
Risk of gastrointestinal perforation in cancer patients treated with vascular endothelial growth factor receptor tyrosine kinase inhibitors: a systematic review and meta-analysisWei-Xiang Qi, Yuan-Jue Sun, Li-Na Tang, et al.
Hua Xi Kou Qiang Yi Xue Za Zhi = Huaxi Kouqiang Yixue Zazhi = West China Journal of Stomatology|August 19, 2021
Short-term efficacy of superficial X-ray treatment for infantile maxillofacial hemangiomaLi-Na Tang, Gang Liu, Chao Yang, et al.
Medical Oncology (Northwood, London, England)|July 13, 2011
Evaluation of pirarubicin-cisplatin chemotherapy in the treatment for refractory and recurrent high-grade osteosarcoma: experience of a single instituteWei-Xiang Qi, Ai-Na He, Li-Na Tang, et al.
Lung|October 12, 2011
The role of vandetanib in the second-line treatment for advanced non-small-cell-lung cancer: a meta-analysis of four randomized controlled trialsWei-Xiang Qi, Li-Na Tang, Ai-Na He, et al.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|September 13, 2014
[Evaluation of the sedative and hypnotic effects of H1208]Jing-Wen Dong, Yuan Shi, Li-Na Tang, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Huan Jing Ke Xue= Huanjing Kexue|December 17, 2008
[Photocatalytic reduction of nitrate using metal-doped titania]Li-na Tang, Li-fen Liu, Xiao-yan Dong, et al.
Ying Yong Sheng Tai Xue Bao = the Journal of Applied Ecology|April 19, 2008
[Ecological classification system of forest landscape in eastern mountainous region of Liaoning Province]Li-na Tang, Qing-li Wang, Li-min Dai, et al.
World Journal of Gastrointestinal Oncology|April 16, 2025
Clinical observation of nivolumab combined with cabozantinib in the treatment of advanced hepatocellular carcinomaLu-Wen Liang, Rong-Hong Luo, Zhi-Li Huang, et al.
Oncology Letters|October 8, 2014
Comparison of pemetrexed plus cisplatin with gemcitabine plus docetaxel in refractory/metastatic osteosarcoma: Clinical outcomes from a retrospective database monitored in a single instituteWen-Xi Yu, Li-Na Tang, Feng Lin, et al.
Journal of Cancer Research and Clinical Oncology|January 20, 2012
Effectiveness and safety of pemetrexed-based doublet versus pemetrexed alone as second-line treatment for advanced non-small-cell lung cancer: a systematic review and meta-analysisWei-Xiang Qi, Li-Na Tang, Ai-Na He, et al.
Critical Reviews in Oncology/Hematology|November 5, 2013
Risk of gastrointestinal perforation in cancer patients treated with vascular endothelial growth factor receptor tyrosine kinase inhibitors: a systematic review and meta-analysisWei-Xiang Qi, Yuan-Jue Sun, Li-Na Tang, et al.
Hua Xi Kou Qiang Yi Xue Za Zhi = Huaxi Kouqiang Yixue Zazhi = West China Journal of Stomatology|August 19, 2021
Short-term efficacy of superficial X-ray treatment for infantile maxillofacial hemangiomaLi-Na Tang, Gang Liu, Chao Yang, et al.
Medical Oncology (Northwood, London, England)|July 13, 2011
Evaluation of pirarubicin-cisplatin chemotherapy in the treatment for refractory and recurrent high-grade osteosarcoma: experience of a single instituteWei-Xiang Qi, Ai-Na He, Li-Na Tang, et al.
Lung|October 12, 2011
The role of vandetanib in the second-line treatment for advanced non-small-cell-lung cancer: a meta-analysis of four randomized controlled trialsWei-Xiang Qi, Li-Na Tang, Ai-Na He, et al.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|September 13, 2014
[Evaluation of the sedative and hypnotic effects of H1208]Jing-Wen Dong, Yuan Shi, Li-Na Tang, et al.
Pageof 7